Seven Bridges closes $45M series A

Biomedical data analysis company Seven Bridges Genomics Inc. (Cambridge, Mass.) raised $45 million in a series A round led by Kryssen Capital. The company's Seven Bridges Platform comprises a cloud-based tools suite that allows academic, government and industry researchers to store and analyze genomic data in tandem with other biomedical data.

Separately on Tuesday, Seven Bridges unveiled the Seven Bridges Cancer Genomics Cloud, which the company developed as part of the National Cancer Institute's Cancer Genomics Cloud Pilots program. Seven Bridges received a contract to develop infrastructure and a set of tools to access and analyze molecular data, including genomic data available through NIH's tumor-sequencing initiative, The Cancer Genome Atlas (TCGA). ...